|
JARID2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.974300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.419800E-02 |
| Normal-vs-Stage2 |
1.721770E-01 |
| Normal-vs-Stage3 |
2.016200E-01 |
| Normal-vs-Stage4 |
1.398340E-03 |
| Stage1-vs-Stage2 |
4.740200E-01 |
| Stage1-vs-Stage3 |
6.565400E-01 |
| Stage1-vs-Stage4 |
4.146100E-02 |
| Stage2-vs-Stage3 |
9.111400E-01 |
| Stage2-vs-Stage4 |
2.719800E-02 |
| Stage3-vs-Stage4 |
5.016300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.500270E-02 |
| Normal-vs-AfricanAmerican |
9.014400E-02 |
| Normal-vs-Asian |
9.178600E-01 |
| Caucasian-vs-AfricanAmerican |
5.580200E-01 |
| Caucasian-vs-Asian |
4.311400E-01 |
| AfricanAmerican-vs-Asian |
4.423800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.041100E-03 |
| Normal-vs-Female |
9.617000E-01 |
| Male-vs-Female |
9.277900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.069700E-02 |
| Normal-vs-Extreme_Weight |
4.739900E-03 |
| Normal-vs-Obese |
1.420570E-01 |
| Normal-vs-Extreme_Obese |
2.042000E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.954400E-01 |
| Normal_Weight-vs-Obese |
4.737000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.082800E-01 |
| Extreme_Weight-vs-Obese |
1.056410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.530800E-01 |
| Obese-vs-Extreme_Obese |
2.052400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.216600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.799970E-01 |
| Normal-vs-Age(61-80Yrs) |
6.664200E-03 |
| Normal-vs-Age(81-100Yrs) |
1.381050E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.938100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.357460E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.247300E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.472100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.954600E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.017800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.386220E-02 |
| Normal-VS-Type2 PRCC |
2.192900E-04 |
| Normal-VS-KIRP CIMP |
7.062000E-01 |
| Normal-VS-Unclassified PRCC |
8.637200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.975900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
5.415900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.489180E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.978900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.876520E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.119800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.463990E-03 |
| Normal-vs-N1 |
6.462800E-01 |
| Normal-vs-N2 |
3.275900E-02 |
| N0-vs-N1 |
4.057500E-02 |
| N0-vs-N2 |
5.641000E-01 |
| N1-vs-N2 |
2.032800E-01 |
|
|
